• settings
  • CC
  • 360p
  • 480p
  • 720p
  • 1080p
1,217 VIEWS | 1 LIKES

SPR as a New Technology in Clinical Research

from Bio-Rad Life Sciences

"For more info, visit Infliximab is a chimeric monoclonal antibody that targets tumor necrosis factor-alpha and is used to treat a variety of chronic autoimmune disorders such as rheumatoid arthritis, Crohn's disease and ulcerative colitis. Monitoring serum infliximab concentrations is important in guiding disease management, especially when a patient is not responding well to treatment. Infliximab concentrations can determine if loss of efficacy is due to inadequate dose or to the development of anti-infliximab antibodies. Currently, 3 reference labs offer quantitative infliximab testing. However, the high cost of these tests limits frequency of use. Here, using the ProteOn XPR36, we describe development of a quantitative assay for infliximab in serum, and explore the practicality of using surface plasmon resonance in the clinical lab."

about 3 years ago

Recommended Videos

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy